会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Non-nucleoside reverse transcriptase inhibitors
    • 非核苷逆转录酶抑制剂
    • US06716850B2
    • 2004-04-06
    • US10092752
    • 2002-03-05
    • Stefan LindströmChrister SahlbergHans WallbergGenaidy KalyanovLourdes Salvador OdénLotta Naeslund
    • Stefan LindströmChrister SahlbergHans WallbergGenaidy KalyanovLourdes Salvador OdénLotta Naeslund
    • C07D40512
    • C07D417/12A61K31/4433A61K31/4436C07C43/23C07C245/18C07D307/93C07D405/12C07D409/12C07D413/12
    • Compounds of the formula I: where; R1 is O, S; R2 is an optionally substituted nitrogen-containing heterocycle, wherein the nitrogen is located at the 2 position relative to the (thio)urea bond; R3 is H, C1-C3 alkyl, R4-R7 are independently selected from H, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, haloC1-C6 alkyl, C1-C6 alkanoyl, haloC1-C6 alkanoyl, C1-C6 alkoxy, haloC1-C6 alkoxy, C1-C6 alkyloxy-C1-C6 alkyl, haloC1-C6 alkyloxy-C1-C6 alkyl hydroxy-C1-C6 alkyl, amino-C1-C6 alkyl, carboxy-C1-C6 alkyl, cyano-C1-C6 alkyl, amino, carboxy, carbamoyl, cyano, halo, hydroxy, keto; X is —(CHR8)n-—D—(CHR8)m—; D is —NR9—, —O—, —S—, —S(═O)— or —S(═O)2—; R8 is independently H, C1-C3 alkyl, halo substitutedC1-C3alkyl; R9 is H, C1-C3 alkyl; n and m are independently 0, 1 or 2; and prodrugs and pharmaceutically acceptable salts thereof, have utility as inhibitors of HIV-1 reverse transcriptase, particularly drug escape mutants.
    • 式I化合物:其中R 1为O,S; R 2为任选取代的含氮杂环,其中氮位于相对于(硫)脲键的2位; R 3为H,C 1 -C 3烷基 ,R 4 -R 7独立地选自H,C 1 -C 6烷基,C 2 -C 6烯基,C 2 -C 6炔基,卤代C 1 -C 6烷基,C 1 -C 6烷酰基,卤代C 1 -C 6烷酰基,C 1 -C 6烷氧基,卤代C 1 -C 6烷氧基, C 1 -C 6烷氧基-C 1 -C 6烷基,卤代C 1 -C 6烷氧基-C 1 -C 6烷基羟基-C 1 -C 6烷基,氨基-C 1 -C 6烷基,羧基-C 1 -C 6烷基,氰基-C 1 -C 6烷基,氨基,羧基 ,氨基甲酰基,氰基,卤素,羟基,酮基; X是 - (CHR 8)n -D-(CHR 8)m - ; D是-NR 9 - , - O - , - S - , - S(= O) - 或 -S(= O)2 - ; R 8独立地是H,C 1 -C 3烷基,卤素取代的C 1 -C 3烷基; R 9是H,C 1 -C 3烷基; n和m独立地是0,1或2;以及前药和药学上可接受的盐 具有用作HIV-1逆转录酶的抑制剂,特别是药物逃逸突变体。